Corcept Therapeutics Incorporated (CORT)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 139,733 | 106,140 | 101,418 | 112,512 | 106,011 |
| Revenue | US$ in thousands | 675,040 | 482,375 | 401,858 | 365,978 | 353,874 |
| Net profit margin | 20.70% | 22.00% | 25.24% | 30.74% | 29.96% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $139,733K ÷ $675,040K
= 20.70%
Based on the provided data, Corcept Therapeutics Incorporated's net profit margin has displayed a slight fluctuation over the five years from 2020 to 2024. The company's net profit margin stood at 29.96% in December 31, 2020, and increased to 30.74% by December 31, 2021, indicating an improvement in the company's profitability.
However, in the following years, the net profit margin experienced a decline, falling to 25.24% by December 31, 2022, 22.00% by December 31, 2023, and 20.70% by December 31, 2024. This downward trend suggests that Corcept Therapeutics may be facing challenges in maintaining profitability or controlling costs in the later years of the data provided.
It is important for the company to analyze the factors contributing to the decreasing net profit margin and implement strategies to improve efficiency, streamline operations, or optimize revenue generation to sustain profitability in the future.
Peer comparison
Dec 31, 2024